What is Span Divergent share price return in the past 10 years?

Span Divergent Ltd share price has declined -4.4% annually (CAGR) over the past ten years.

Span Divergent Ltd - Stock Valuation and Financial Performance

Name: Span Divergent
Brand: Span Divergent

BSE: 524727 | NSE: | Chemicals | Small Cap

Place order

Span Divergent Share Price

₹31.98 -1.68 -4.99%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Span Divergent

Based on:

Data

M-Cap below 100cr DeciZen not available

Span Divergent stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

11.35

Market Cap:

17.5 Cr.

52-wk low:

12.9

52-wk high:

45.3

Is Span Divergent Ltd an attractive stock to invest in?

1. Is Span Divergent Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Span Divergent Ltd is a below average quality company.

2. Is Span Divergent Ltd undervalued or overvalued?

The key valuation ratios of Span Divergent Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Span Divergent Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Span Divergent Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Span Divergent:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	75.1%	8.7%	-1%	-3.6%	-5.6%	-0.6%	0.1%	-19%	-9%	4.3%	-
Value Creation Index ⓘ	4.4	-0.4	-1.1	-1.3	-1.4	-1.0	-1.0	-2.4	-1.6	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	72.9	0	2.4	1.7	1.7	1.7	1.5	2	2	1.9	0
Sales YoY Gr.	-	-100%	NA	-28.9%	1.8%	-1.2%	-14.6%	34.3%	0%	-2.6%	-
Adj EPS ⓘ	1.9	-3.5	-5.1	-7.5	-3.9	-1.1	-0.1	-3.1	-1.1	1.4	2.8
YoY Gr.	-	-286.2%	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	80.8	92.5	92.4	86.8	80.7	80.1	80.1	65.9	59.7	62.5	63.8
Adj Net Profit ⓘ	1.4	-1.9	-2.8	-4.1	-2.1	-0.6	0	-1.7	-0.6	0.8	2
Cash Flow from Ops. ⓘ	45	-4.1	-0.9	2.4	-1.1	1.1	0.4	-0.3	0.6	0.5	-
Debt/CF from Ops. ⓘ	0	0	-9.1	4	-3.8	2.2	7.4	-8.4	4.4	3.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-33.3%	2%	9.4%	-2.6%
Adj EPS ⓘ	-3.3%	NA	NA	NA
BVPSⓘ	-2.8%	-5%	-7.9%	4.6%
Share Price	-4.4%	16.9%	34.7%	126.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	3.3	-3.5	-5.5	-8.4	-4.6	-1.4	-0.1	-4.3	-1.7	2.3	4.5
Op. Profit Mgn % ⓘ	2.1	0	-175.9	-252.9	-71.8	-17.4	4.8	23.2	25.5	11.5	NAN
Net Profit Mgn % ⓘ	1.9	0	-116.4	-242.5	-121.9	-35.2	-2.5	-87.1	-30.1	39.7	INF
Debt to Equity ⓘ	0	0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Working Cap Days ⓘ	117	0	1,291	1,027	289	532	721	308	275	290	0
Cash Conv. Cycle ⓘ	57	0	-1	24	49	33	9	-6	11	25	0

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 4.50%

Sales growth has been subdued in last 3 years 9.37%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Span Divergent Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2.8	2.1
TTM Sales (₹ Cr.)	0	11.9
BVPS (₹.) ⓘ	63.8	-3.5
Reserves (₹ Cr.) ⓘ	29	-7
P/BV ⓘ	0.50	-9.07
PE ⓘ	11.35	15.01

From the Market
52 Week Low / High (₹)	12.92 / 45.30
All Time Low / High (₹)	1.20 / 101.50
Market Cap (₹ Cr.)	17.5
Equity (₹ Cr.)	5.5
Face Value (₹)	10
Industry PE ⓘ	57.2

Management X-Ray of Span Divergent:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Span Divergent

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Span Divergent

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	72.87	0	2.39	1.70	1.73	1.71	1.46	1.96	1.96	1.91
Operating Expenses ⓘ	71.39	5.25	6.58	5.98	2.97	2.01	1.39	3.20	1.46	1.69
Manufacturing Costs	19.97	0.01	0.04	0.06	0.06	0.06	0.06	0.07	0.06	0.07
Material Costs	19.76	0	1.56	0.07	0	0	0	0	0	0
Employee Cost	16.56	0.57	1.63	3.14	1.71	1.37	0.95	1.14	1.04	1.18
Other Costs ⓘ	15.10	4.68	3.35	2.72	1.20	0.57	0.37	1.98	0.35	0.45
Operating Profit ⓘ	1.48	-5.25	-4.20	-4.29	-1.24	-0.30	0.07	-1.23	0.50	0.22
Operating Profit Margin (%)	2.0%	-	-175.0%	-252.0%	-71.8%	-17.4%	4.8%	-62.9%	25.5%	11.5%
Other Income ⓘ	2.13	2.74	4.02	3.41	1.23	1.49	1.75	2.84	0.74	1.55
Interest ⓘ	4.36	0	0.17	0.70	0.17	0.23	0.04	0	0	0
Depreciation ⓘ	5.83	0.17	0.34	0.56	1.12	0.92	0.65	0.51	0.42	0.34
Exceptional Items ⓘ	47.27	7.42	0	-0.64	-1.83	-0.54	-1.11	-9.17	-4.11	0.08
Profit Before Tax ⓘ	40.68	4.74	-0.69	-2.78	-3.13	-0.49	0.02	-8.07	-3.30	1.51
Tax ⓘ	5.53	1.21	0.16	0.30	0.11	-0.14	0.02	-0.32	0.04	0
Profit After Tax	35.15	3.53	-0.84	-3.08	-3.24	-0.35	0	-7.76	-3.34	1.51
PAT Margin (%)	48.2%	-	-35.4%	-181.0%	-187.0%	-20.5%	-0.1%	-395.0%	-170.0%	78.9%
Adjusted EPS (₹)	48.3	6.5	-1.6	-5.6	-5.9	-0.6	0.0	-14.2	-6.1	2.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	58.79	50.53	50.49	47.41	44.09	43.72	43.73	35.97	32.62	34.12
Share Capital ⓘ	7.28	5.46	5.46	5.46	5.46	5.46	5.46	5.46	5.46	5.46
Reserves ⓘ	51.51	45.07	45.03	41.95	38.63	38.26	38.27	30.51	27.16	28.66
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	8.50	9.80	4.17	2.42	2.76	2.56	2.54	1.98
Long Term Debt	0	0	1.90	0.09	0.07	1.49	2.76	2.56	2.54	1.98
Short Term Debt	0	0	6.60	9.70	4.10	0.93	0	0	0	0
Trade Payables	0.06	0.09	0.13	0.02	0.09	0.13	0.20	0.06	0.06	0.02
Others Liabilities ⓘ	3.47	0.36	0.88	1.62	1.25	3.14	3.16	2.20	2.33	2.25
Total Liabilities ⓘ	62.33	50.98	60	58.84	49.60	49.41	49.85	40.79	37.55	38.36
Fixed Assets
Gross Block	0.64	2.53	5.28	8.93	8.92	9.37	7.11	6.99	7	7
Accumulated Depreciation	0.25	0.41	0.76	1.01	1.71	4.53	2.72	3.08	3.40	3.68
Net Fixed Assetsⓘ	0.40	2.12	4.53	7.91	7.21	4.85	4.39	3.91	3.59	3.31
CWIP ⓘ	0	0.03	0.92	0	0.01	0.02	0.02	0	0	0
Investmentsⓘ	46.36	38.39	46.14	48.39	40.74	40.70	42.88	35.10	31.86	33.22
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0	0.13	0	0.29	0.24	0.23	0.12	0.10	0.16	0.19
Cash Equivalents	9.54	1.57	0.41	0.98	0.45	0.04	0.13	0.05	0.25	0.38
Others Assetsⓘ	6.04	8.75	8	1.26	0.94	3.57	2.31	1.63	1.69	1.27
Total Assets ⓘ	62.33	50.98	60	58.84	49.60	49.41	49.85	40.79	37.55	38.36

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	44.99	-4.14	-0.93	2.44	-1.09	1.10	0.37	-0.31	0.58	0.53
PBT ⓘ	-6.59	-2.68	-0.69	-2.78	-3.13	-0.49	0.02	-8.07	-3.30	1.51
Adjustment ⓘ	9.71	-1.75	-1.52	-1.52	1.89	0.20	0.05	8.55	3.97	-1
Changes in Working Capital ⓘ	3.2	-5.14	0.68	6.58	0.04	1.46	0.37	-0.71	0.02	0.07
Tax Paid ⓘ	-8.60	-1.99	0.59	0.16	0.11	-0.06	-0.06	-0.07	-0.11	-0.05
Cash Flow From Investing Activity ⓘ	-5.83	10.26	-8.56	-2.52	6.39	0.47	-0.57	0.43	-0.36	0.16
Capex	40.56	-1.92	-5	-2.20	0.03	0.10	2.01	0.97	-0.01	0.90
Net Investments	-45.52	7.97	-4.80	-1.42	5.61	-0.22	-3.18	-1.13	-0.87	-1.30
Others ⓘ	-0.87	4.21	1.24	1.09	0.76	0.59	0.59	0.59	0.52	0.56
Cash Flow From Financing Activityⓘ	-32.35	-12.16	8.33	0.67	-5.82	-1.97	0.30	-0.20	-0.02	-0.56
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-8.63	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-4.36	0	-0.17	-0.70	-0.17	-0.22	-0.04	0	0	0
Dividend Paid ⓘ	0	0	0	-0.01	-0.02	0	-0.01	0	0	0
Others ⓘ	-19.36	-12.16	8.50	1.39	-5.63	-1.75	0.34	-0.20	-0.02	-0.56
Net Cash Flow ⓘ	6.81	-6.04	-1.16	0.59	-0.52	-0.41	0.10	-0.08	0.20	0.13

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	85.19	6.46	-1.67	-6.29	-7.09	-0.8	0	-19.47	-9.73	4.52
ROCE (%)	75.09	8.68	-0.95	-3.57	-5.62	-0.55	0.13	-18.99	-8.95	4.25
Asset Turnover Ratio	0.97	0	0.04	0.03	0.03	0.03	0.03	0.04	0.05	0.05
PAT to CFO Conversion(x)	1.28	-1.17	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.35
Working Capital Days
Receivable Days	0	0	0	62	56	50	44	21	25	34
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	97	0	25	387	0	0	0	0	0	0

Span Divergent Ltd Stock News

Span Divergent Ltd FAQs

What is the share price of Span Divergent?

Company share prices are keep on changing according to the market conditions. The closing price of Span Divergent on 20-Dec-2024 16:59 is ₹31.98.

What is the market cap of Span Divergent?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Span Divergent stood at ₹17.47.

What is the P/E ratio of Span Divergent?

The latest P/E ratio of Span Divergent as of 20-Dec-2024 16:59 is 11.35.

What is the P/B ratio of Span Divergent?

The latest P/B ratio of Span Divergent as of 20-Dec-2024 16:59 is 0.50.

What is the 52-week high and low of Span Divergent?

The 52-week high of Span Divergent is ₹45.30 and the 52-week low is ₹12.92.

What is the TTM revenue of Span Divergent?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Span Divergent is ₹0.00 ( Cr.) .

About Span Divergent Ltd

A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil.

The initial efforts yielded success and SPAN became a private limited company in 1981.The company went public in 1994,to bring in more resources and expand further Concurrently , Span Diagnostics Ltd. with a strengthened marketing & distribution network, emerged as a leader in Indian diagnostic market.

Today, SPAN â€“ a legendary name in the industry is reckoned for its wide range of quality products and dedicated services. The company operates through strategic marketing divisions, ensuring focused approach to specific customer segments.

Span Diagnostics Ltd. is a pioneer and trend setter of high quality products for pathology & clinical laboratories in the Indian diagnostics industry. A globally acknowledged and fastest growing diagnostic company with a successful track record of over 3 decades having Asia's one of the largest state-of-the-art ISO-9001:2000, WHO cGMP accredited advanced manufacturing facilities with ISO 13485 & CE accredited products. We have our marketing activities across India and 68 countries worldwide. SPAN services end users and distributors with ready to use testing kits and customized OEM products.

SPAN has nurtured its growth by consistently adding new products through R & D endeavors. The products are manufactured at its state-of-the-art plants in India and France , observing WHO- cGMP norms.

SPAN also takes pride in having exclusive strategic business alliances with the leading diagnostic companies from world over, to market their products in India.

Product range of the company includes